Insider Shareholders with Direct Ownership of Azenta, Inc. (AZTA)
This section provides a comprehensive overview of the insiders with direct ownership of Azenta, Inc. (AZTA). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
Azenta, Inc. Insider List
| Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
|---|---|---|---|---|---|
| 253,824 | 153,331 | 446,536 $13.3 Million | 12 |
Nov 16, 2023
Added 4.79%
|
|
|
John Marotta
President and CEO |
229,563 | 11,296 | 217,268 $6.46 Million | 10 |
Nov 24, 2025
Added 36.01%
|
|
Lindon G Robertson
EVP & Chief Financial Officer |
102,443 | 45,184 | 121,081 $3.6 Million | 16 |
Nov 16, 2023
Reduced 2.24%
|
|
Jason Joseph
SVP, General Counsel, Secy. |
82,945 | 47,111 | 112,564 $3.35 Million | 24 |
Nov 19, 2024
Reduced 1.0%
|
|
Mark S Wrighton
Director |
3,682 | 1,450 | 111,818 $3.33 Million | 3 |
Feb 11, 2022
Added 1.69%
|
|
Krishna G. Palepu
Director |
7,286 | 0 | 105,393 $3.14 Million | 3 |
Feb 13, 2023
Added 3.31%
|
|
William T. Montone
SVP, Human Resources |
8,980 | 17,915 | 91,936 $2.74 Million | 5 |
Sep 27, 2021
Reduced 4.31%
|
|
Joseph R Martin
Director |
10,338 | 3,400 | 85,175 $2.53 Million | 5 |
Jun 06, 2023
Reduced 2.74%
|
|
Lawrence Y. Lin
EVP, CFO and Treasurer |
76,194 | 3,039 | 79,655 $2.37 Million | 7 |
Nov 24, 2025
Added 31.53%
|
|
David C Gray
Chief Strategy & New Business |
50,669 | 47,991 | 74,868 $2.23 Million | 14 |
Nov 17, 2023
Reduced 6.47%
|
|
Ephraim Starr
SVP, Gen Counsel & Secretary |
72,014 | 0 | 72,014 $2.14 Million | 2 |
Nov 24, 2025
Added 32.22%
|
|
David Jarzynka
President, Semi Solutions |
43,414 | 76,366 | 46,315 $1.38 Million | 5 |
Nov 19, 2021
Reduced 18.07%
|
|
Ellen M Zane
Director |
7,286 | 18,766 | 41,134 $1.22 Million | 4 |
Aug 08, 2023
Reduced 31.33%
|
|
Ginger Zhou
SVP and GM, Multiomics |
37,541 | 3,832 | 38,755 $1.15 Million | 17 |
Nov 24, 2025
Added 25.18%
|
| 13,791 | 0 | 33,627 $1 Million | 5 |
Feb 07, 2025
Added 10.73%
|
|
|
Olga Pirogova
SVP and CHRO |
36,224 | 3,186 | 33,038 $982,880 | 7 |
Nov 24, 2025
Added 33.04%
|
|
Robin Vacha
SVP, GM Life Science Products |
59,099 | 43,217 | 31,287 $930,788 | 20 |
Feb 01, 2024
Added 1.02%
|
|
Matthew Mc Manus
EVP & Chief Operating Officer |
8,625 | 0 | 29,467 $876,643 | 1 |
Aug 19, 2022
Added 22.64%
|
|
David Pietrantoni
Principal Accounting Officer |
17,224 | 25,287 | 27,375 $814,406 | 7 |
Nov 17, 2021
Reduced 2.95%
|
|
David Dong Wang
SVP & GM, SMS |
18,191 | 626 | 23,974 $713,226 | 6 |
Dec 04, 2024
Reduced 0.58%
|
|
Herman Cueto
EVP, Chief Financial Officer |
26,199 | 2,307 | 23,892 $710,787 | 4 |
Nov 19, 2024
Reduced 2.89%
|
| 17,035 | 0 | 17,035 $506,791 | 3 |
May 30, 2025
Added 41.33%
|
|
| 13,791 | 0 | 16,858 $501,525 | 5 |
Feb 07, 2025
Added 19.33%
|
|
| 14,560 | 0 | 14,560 $433,160 | 5 |
Feb 07, 2025
Added 26.2%
|
|
| 9,751 | 4,591 | 13,042 $387,999 | 6 |
Feb 12, 2024
Added 15.9%
|
|
|
Guojuan Liao
President, GENEWIZ |
3,102 | 1,354 | 12,827 $381,603 | 2 |
Nov 18, 2020
Reduced 9.55%
|
| 7,644 | 2,465 | 10,109 $300,742 | 3 |
Feb 07, 2025
Added 28.55%
|
|
|
Violetta Hughes
VP, Chief Accounting Officer |
8,295 | 1,375 | 9,603 $285,689 | 6 |
Feb 03, 2025
Reduced 3.2%
|
| 7,405 | 0 | 7,405 $220,298 | 2 |
Nov 19, 2024
Added 40.02%
|
|
|
Kimberly Crowley
SVP, Chief HR Officer |
4,042 | 706 | 7,399 $220,120 | 7 |
Jan 31, 2023
Added 2.34%
|
|
Vandana Sriram
SVP Finance & Corp. Controller |
3,180 | 81 | 6,356 $189,091 | 4 |
Jan 31, 2023
Added 5.49%
|
|
Quentin Koffey
Director |
5,035 | 0 | 5,035 $149,791 | 2 |
Feb 07, 2025
Added 44.52%
|
| 4,040 | 0 | 4,040 $120,190 | 1 |
Feb 07, 2025
Added 50.0%
|
|
|
Dorothy E Puhy
Director |
3,604 | 0 | 3,604 $107,219 | 1 |
Feb 13, 2023
Added 50.0%
|
| 3,465 | 0 | 3,465 $103,083 | 2 |
Nov 18, 2024
Added 22.4%
|
|
|
Linda De Jesus
Chief Commercial Officer, LS |
1,635 | 191 | 2,764 $82,229 | 4 |
Jul 29, 2022
Added 1.53%
|
| 0 | 2,465 | 2,465 $73,333 | 1 |
Feb 12, 2024
Reduced 50.0%
|
|
| 0 | 995 | 2,255 $67,086 | 1 |
Nov 06, 2024
Reduced 30.62%
|
|
|
Mitchell Coyne
SVP and GM, Life Sciences Proj |
1,889 | 0 | 1,889 $56,197 | 1 |
Nov 17, 2022
Added 50.0%
|